ArticleFrontiers in pharmacology2022

Norcantharidin ameliorates estrogen deficient-mediated bone loss by attenuating the activation of extracellular signal-regulated kinase/ROS/NLRP3 inflammasome signaling.

Guang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.